ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Koninklijke Philips NV

Koninklijke Philips NV (PHIA)

25.67
0.45
( 1.78% )
업데이트: 00:04:03

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
25.67
매수가
25.67
매도가
25.68
거래량
371,448
25.37 일간 변동폭 25.70
18.034 52주 범위 30.22
market_cap
전일 종가
25.22
개장가
25.42
최근 거래 시간
90
@
25.67
마지막 거래 시간
00:04:13
재정 규모
-
VWAP
-
평균 볼륨(3m)
1,784,914
발행 주식
906,403,000
배당수익률
-
주가수익률
-49.78
주당순이익(EPS)
-0.51
매출
18.17B
순이익
-466M

Koninklijke Philips NV 정보

섹터
Electrical Machy, Equip, Nec
산업
Electrical Equipment
웹사이트
본부
Eindhoven, North Brabant, Nld
설립됨
1984
Koninklijke Philips NV is listed in the Electrical Machy, Equip sector of the 유로넥스트 (Euronext) with ticker PHIA. The last closing price for Koninklijke Philips NV was 25.22 €. Over the last year, Koninklijke Philips NV shares have traded in a share price range of 18.034 € to 30.22 €.

Koninklijke Philips NV currently has 906,403,000 shares in issue. The market capitalisation of Koninklijke Philips NV is 22.86 € billion. Koninklijke Philips NV has a price to earnings ratio (PE ratio) of -49.78.

PHIA 최신 뉴스

Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24

Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24 November 25, 2024icometrix’ FDA-cleared quantitative brain solution for...

Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24

Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24 Nov. 21, 2024 Industry’s first wide bore, high-performance helium-free [1]...

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease With a unique world-first ability to perform laser atherectomy and...

Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world

Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world October 28, 2024 Third-quarter highlights Group sales...

Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments

Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments October 24, 2024 Both companies also join the newly established World Stroke Organization...

Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy

Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy October 7, 2024 Jakarta, Indonesia and Amsterdam, the Netherlands – Royal...

Pioneering hospitals take major steps towards decarbonizing healthcare with Philips

Pioneering hospitals take major steps towards decarbonizing healthcare with Philips October 3, 2024 Philips helps healthcare organizations worldwide assess and mitigate their environmental impact...

Jackson Health System projects 47% reduction in carbon emissions from patient monitors with Philips next generation monitoring platform

Jackson Health System projects 47% reduction in carbon emissions from patient monitors with Philips next generation monitoring platform Opportunity for significant savings in energy consumption...

World Stroke Organization and Philips call for action to expand access to life-saving stroke care

World Stroke Organization and Philips call for action to expand access to life-saving stroke care September 10, 2024 Joint policy paper provides recommendations for effective policymaking and...

Carilion Clinic further expands quality cardiac care access with latest Philips innovations at new regional cardiovascular institute in Virginia, US

Carilion Clinic further expands quality cardiac care access with latest Philips innovations at new regional cardiovascular institute in Virginia, US August 20, 2024 Integrated Philips...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.174.7755102040824.525.7424.2134428324.83665188DE
4-0.53-2.0229007633626.226.2123.8245759524.72159174DE
12-1.61-5.9017595307927.2830.2223.8178491426.79882501DE
260.72.8033640368424.9730.2223.05173889025.96607478DE
526.14631.479205080919.52430.2218.034208233422.99819202DE
156-9.235-26.457527574834.90535.0212.13290303521.00252528DE
260-15.73-37.995169082141.450.9812.13279722627.67297373DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ATOAtos SE
0.3535 €
(126.60%)
25.31M
ALIMOGroupimo
0.276 €
(46.03%)
100
ALROCRoctool
0.398 €
(36.30%)
261.93k
ALARFAdeunis
0.784 €
(20.99%)
2.94k
ALNMRNamR SA
0.46 €
(15.00%)
91
BIDSGascogne DS
0.003 €
(-40.00%)
75.69k
ALMERSapmer
6.40 €
(-14.67%)
2
ALBDMBD Multi-Media
1.14 €
(-11.97%)
204
ALDEVDevernois Sa
10.30 €
(-11.97%)
7
TVRBAction Televerbier
48.60 €
(-11.64%)
2
BCPBanco Comercial Portugues SA
0.45 €
(1.21%)
35.33M
ATOAtos SE
0.3535 €
(126.60%)
25.31M
ALNEVNeovacs
0.0002 €
(0.00%)
23.05M
ALTDTonner Drones
0.011 €
(10.00%)
12.83M
LATLatecoere
0.0075 €
(5.63%)
10.76M
Doc328 Doc328 4 분 전
Alzheimer's & Dementia would be a good journal to publish the study. They actually do recommend that the SAP be uploaded. However, the 2020 phase 2a paper did not include this in the supporting/supplementary data. The SAP / protocol for a phase 2 trial is less important as it is not a registrati
AVXL
GVInvestments GVInvestments 4 분 전
Thats great news, thanks for sharing. Can we get more information on there business friendship.
FNMA
tmcfo tmcfo 4 분 전
Company silence since the august post has been deafening..they must be too busy producing Xmax gifts for shareholders!
MVNT
JoJr JoJr 4 분 전
Full blown .0011's
Not the half baked .00105
Up 22%
RDAR
LarryBear40 LarryBear40 4 분 전
Yeah Nick, let me in please. @LarryAWood1

Thanks.
AAGC
Julesb Julesb 4 분 전
I just read the last paragraphs from large pharma companies quarterly meeting transcripts and majority of them including McKesson are looking to acquire companies. The pharma acquisition and merger forecast is forecast to be huge in 2025.

ELTP
Techroemancer Techroemancer 4 분 전
It says it right in the financials Steal,

$GEVI These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.

And the countdown begins
GEVI
williams45 williams45 4 분 전
$NNVC gains 2.81%, now $1.3776—progress fueling excitement!
https://iotracker96.com/Ry2vp
NNVC
KPIFF-LDDFF KPIFF-LDDFF 5 분 전
KPIFF
NewJerichoMan NewJerichoMan 5 분 전
Another tweet: https://x.com/BlueBiofuels/status/1861064314641125480
BIOF
trunkmonk trunkmonk 5 분 전
I hates gaps here, will this be a runaway gap, will volume sustain it, if not, fill and then go back up.
FNMA
glenn1919 glenn1919 5 분 전
VUZI..................MULN.......................https://stockcharts.com/h-sc/ui?s=MULN&p=W&b=5&g=0&id=p84354014936
MULN VUZI
Techroemancer Techroemancer 5 분 전
GEVI has ONLY 4 customers and Q1 only did GROSS revs of $400k and last 2 Qs tad over $100k gross revenue per Q, Lost 5 million and NOW GEVI as per S1 statement and what was stated in the recent Q subsequent events we can do the math and that GEVI is planning to sell their Offering of 3,500,000 to ra
GEVI
peanutz peanutz 5 분 전
I don't believe they do . They need some cheese to go with their " wine" LOL
IGPK
scotty3371 scotty3371 5 분 전
When shares trade on the offer they offer at a lower price, when shares trade on the bid, bid goes lower.

 
NWBO
barrydingle barrydingle 5 분 전
You want to reap a reward here?

You've been told how that can happen.
There is no Hans to file anything.

I believe the control person at MEDH is still listed as Jason Black.
I'd say the ball's in his court and he'd better play his hand with shareholders in
MEDH
govprs govprs 5 분 전
Benz selling? 
GDVM
Techroemancer Techroemancer 5 분 전
You still have 3 years per the requirements needed to uplist to NYSE. Below is some education material for you so that you can stop spreading misinformation.

• EARNINGS TEST: Adjusted pre -tax earnings from continuing operations must total (1) $10 million for the last three fiscal yea
GEVI
fink fink 5 분 전
Get burned that bad?

Wow!
IGPK
pos_stock_hoarder pos_stock_hoarder 5 분 전
From Stilton Jarlsberg:
https://blogger.googleusercontent.com/img/a/AVvXsEhYRzA5mGamEKIFwoNlJVqMhdpzLItTQ4F8YWJD5QDrtwpFkA8C9vDVBGu7_C-TVPYR1ktW0yOpMxqFMY8CUX90cYSDT2rpkC9WIxTE6ptGx_goTNUnqr7cy9nV_T5eAbwHTvXdyKoMVKIY-Vqywi3UYFqFTveMvIBIYsa2wdjVLDEyUx1_34GDmy2W07I=w640-h306

More
BIG BALLER BIG BALLER 5 분 전
Gary Gensler is useless , apparently schmoozing with the likes of Sam Bankman-Fried! :p ~realistically how could we expect anything to change under his watch?

...you wanna head the SEC next year? ;) cheers!
Guzzi62 Guzzi62 5 분 전
Our MC is now roughly 4X more than SAVA's

800 mill
200 mill

Biotech is incredibly brutal, and no mercy will be shown if you fail.
AVXL
Budots Budots 6 분 전
Adnexus Biotechnologies Inc., a staking target of 1606 Corp. (OTC PINK: $CBDW), has announced a game-changing merger with Sanctum Therapeutics. https://allcapresearch.com/f/adnexus-biotech-and-sanctum-merge-for-breakthrough-hiv-treatment
CBDW
Budots Budots 6 분 전
Adnexus Biotechnologies Inc., a staking target of 1606 Corp. (OTC PINK: $CBDW), has announced a game-changing merger with Sanctum Therapeutics. https://allcapresearch.com/f/adnexus-biotech-and-sanctum-merge-for-breakthrough-hiv-treatment
CBDW
BigBadWolf BigBadWolf 6 분 전
$RDAR 11's printed
RDAR

최근 히스토리

Delayed Upgrade Clock